Hepatitis C Community
Hepatitis Researcher: fibrosis and cellular immune response
About This Community:

This forum is for questions about medical issues and research aspects of Hepatitis C such as, questions about being newly diagnosed, questions about current treatments, information and participation in discussions about research studies and clinical trials related to Hepatitis. If you would like to communicate with other people who have been touched by Hepatitis, please visit our new Hepatitis Social/Living with Hepatitis forum

Font Size:
A
A
A
Background:
Blank
Blank
Blank
Blank Blank

Hepatitis Researcher: fibrosis and cellular immune response

HR for some time i have been confused about progression of fibrosis relating to viral stimulated immune response.

if the Th1 immune response is pro-inflammatory ( and Th2 response anti-inflammatory) how do the trial drugs that promote the Th1 response work to decrease inflamation (inflammation), ALT levels, and improve histology?

does hcv cause overproduction Th2 cytokines and down regulate Th1 cytokines causing chronic inflammation the reason for fibrotic progression? are immune therapies a good adjunct to prevent worsening of fibrosis to be considered.

thank you for your reply.
Whrose
Related Discussions
Avatar_dr_m_tn
Activation of Th1 means that the subset of helper T lymphocytes that preferentially produce IFN gamma and Il-12 and direct the cytotoxic T cell population as their main effector cell population is in the foreground of activation. This is typically the response that allows to identify virus infected cells via the extremely sensitive class I epitope - T cell receptor system, with subsequent killing of the infected cell AND the secretion of local gamma inteferon that will inhibit and sometimes eradicate the virus in the neighborhood of the recognized cell as well.

Insofar as this reduces intrahepatic viral presence and reduces consequently the general proinflammatory reaction - " hepatitis", and therefore  the collateral activation of hepatic stellate cells, that receive signals from this inflammatory process that turn them into a fiber producing myofibroblast, they indirectly reduce fibrosis in the longer run.

HCV is not intending to increase fibrosis but benefits from lesser Th1 propensity and has evolved some counteractive mechanisms in that regard. The persistence of the virus causes persistent inflammation - see above- and fosters fibrosis in this fashion.

Immune therapies like thymosin alpha are a good adjunct to IFN, since they further strengthen the T cell aspect of the multiple IFN actions. But when the response to IFN is either weak from the host side or inactivated by the virus, or if the virus has found means to inactivate by clever blocking mechanism the actual final IFN and other cytokine actions then they also will not really work.

The US Thymosin alpha trial plus SOC vs SOC in SOC nullresponders was terminated when the response ( SVR) rate was 1%! in SOC and yes three times more with the addition of Thymosin alpha , namely a very very paltry 3%.

On the other hand, in treatment naive patients the addition of Thymosin to SOC will lead to a substantial improvement of SVR rates as I was told from interim results from the large ongoing European trials for this setting.
Blank
Post a Comment
To
Blank
Weight Tracker
Weight Tracker
Start Tracking Now
Hepatitis C Community Resources
RSS Expert Activity
242532_tn?1269553979
Blank
How to Silence Your Inner Critic an...
Apr 16 by Roger Gould, M.D.Blank
242532_tn?1269553979
Blank
Emotional Eaters: How to Silence Yo...
Mar 26 by Roger Gould, M.D.Blank
1344197_tn?1392822771
Blank
Vaginal vs. Laparoscopic Hysterecto...
Feb 19 by J. Kyle Mathews, MD, DVMBlank
Top Hepatitis Answerers
317787_tn?1373214989
Blank
Dee1956
DC
1747881_tn?1358189534
Blank
hrsepwrguy
Greeley, CO
Avatar_m_tn
Blank
willbb
Avatar_m_tn
Blank
copyman
96938_tn?1189803458
Blank
FlGuy
South, FL
163305_tn?1333672171
Blank
orphanedhawk
Rural Mural, CA